{HEAD ~ The present invention} relates to novel compounds that are inhibitors of wild type and mutant dihydrofolate reductase of Plasmodium falciparum, which are useful for the treatment of {TAIL ~ malaria} 
{ HEAD ~ The present invention } relates to novel compounds that are inhibitors of wild type and mutant dihydrofolate reductase of Plasmodium falciparum , which are useful for the treatment of { TAIL ~ malaria }
HEAD HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL